<DOC>
	<DOC>NCT02492880</DOC>
	<brief_summary>This is a prospective, on-label, multi-center, non-randomized, exploratory, single-arm study to characterize the effects of programming features of the Boston Scientific Precision Spectra™ Spinal Cord Stimulator (SCS) System using the CoverEdge™ surgical lead.</brief_summary>
	<brief_title>CoverEdge Algorithm Programming Study</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Subject implanted, onlabel, with a commercially approved Boston Scientific Spectra neurostimulation system and at least one CoverEdge or CoverEdge X surgical lead, per local directions for use (DFU). Subject signed a valid, Institutional Review Board (IRB)approved informed consent form. Subject is 18 years of age or older when written informed consent is obtained. Subject meets any contraindication in Boston Scientific (BSC) neurostimulation system local DFU. Subject is currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or complete study assessments.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>stimulation</keyword>
	<keyword>implantable</keyword>
	<keyword>pulse generator</keyword>
	<keyword>back pain</keyword>
	<keyword>chronic pain</keyword>
	<keyword>leg pain</keyword>
</DOC>